ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
ANGIODYNAMICS INC
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$11.39+0.15 (+1.33%)
Close on Oct 19, 2026
- Market cap
- $478.63M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
91.0%
38M of 42M shares
Institutional holders
162
31 new, 15 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $344.01K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Divisadero Street Capital Management, LP | 3,395,430 | 8.40% | 13G (passive) amendment | Jun 30, 2025 |
| Steven A. Cohen | 3,181,829 | 7.70% | 13G (passive) amendment | Mar 31, 2026 |
| BlackRock, Inc. | 2,918,422 | 7.20% | 13G (passive) amendment | Mar 31, 2025 |
| Systematic Financial Management LP | 2,508,295 | 6.10% | 13G (passive) | Dec 31, 2025 |
| Kevin Kotler | 2,421,526 | 5.90% | 13G (passive) | Jan 6, 2026 |
| William Zolezzi | 2,137,081 | 5.30% | 13G (passive) | Jun 2, 2025 |
| Point72 Asset Management, L.P. | 2,120,202 | 5.20% | 13G (passive) | Jul 16, 2025 |
| Steven Boyd | 2,094,000 | 5.16% | 13G (passive) | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ANGO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,803,232 | 9.04% | $49.48M | +117,328 | 0.00% |
| Point72 Asset Management, L.P. | 3,062,517 | 7.28% | $39.84M | −119,312 | 0.04% |
| Systematic Financial Management LP | 2,640,214 | 6.28% | $34.35M | +186,513 | 0.68% |
| Armistice Capital, LLC | 2,198,000 | 5.23% | $28.60M | +329,000 | 0.35% |
| Royce & Associates LP | 1,969,835 | 4.68% | $25.63M | +440,884 | 0.21% |
| Broadfin Holdings LLC | 1,818,533 | 4.32% | $23.66M | −250,800 | 100.00% |
| Vanguard Capital Management LLC | 1,694,716 | 4.03% | $22.05M | −32,104 | 0.00% |
| Weber Capital Management LLC /Adv | 1,356,602 | 3.23% | $17.65M | −16,547 | 15.02% |
| Nuveen, LLC | 1,199,358 | 2.85% | $15.60M | −16,807 | 0.00% |
| Geode Capital Management, LLC | 1,020,658 | 2.43% | $13.28M | +35,235 | 0.00% |
| Dimensional Fund Advisors LP | 969,497 | 2.31% | $12.61M | +20,682 | 0.00% |
| State Street Corp | 958,167 | 2.28% | $12.47M | −375,691 | 0.00% |
| Segall Bryant & Hamill, LLC | 926,711 | 2.20% | $12.06M | −39,254 | 0.14% |
| Bastion Asset Management Inc. | 923,270 | 2.20% | $10.78M | −389,732 | 3.66% |
| Pier Capital, LLC | 806,678 | 1.92% | $10.49M | +9,982 | 1.39% |
| Millennium Management LLC | 783,125 | 1.86% | $10.19M | +138,448 | 0.00% |
| Renaissance Technologies LLC | 733,883 | 1.75% | $9.55M | −69,400 | 0.01% |
| Arrowstreet Capital, Limited Partnership | 692,534 | 1.65% | $9.01M | −65,916 | 0.00% |
| Paradigm Capital Management Inc/Ny | 671,200 | 1.60% | $8.73M | −47,000 | 0.24% |
| Aqr Capital Management LLC | 589,157 | 1.40% | $7.66M | +337,643 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 162 | 38M | 91.0% | 31 / 56 | 56 / 15 | 3M | 4M |
| Q1 2026 | 147 | 39M | 92.0% | 19 / 54 | 57 / 36 | 8M | 4M |
| Q4 2025 | 167 | 39M | 92.5% | 36 / 55 | 53 / 11 | 7M | 7M |
| Q3 2025 | 144 | 39M | 93.1% | 23 / 55 | 47 / 29 | 5M | 3M |
| Q2 2025 | 150 | 37M | 87.8% | 19 / 55 | 53 / 22 | 6M | 4M |
| Q1 2025 | 154 | 35M | 84.3% | 35 / 46 | 58 / 15 | 9M | 6M |
| Q4 2024 | 135 | 33M | 79.4% | 22 / 52 | 45 / 25 | 6M | 5M |
| Q3 2024 | 138 | 33M | 78.1% | 21 / 57 | 37 / 21 | 10M | 4M |
| Q2 2024 | 140 | 33M | 78.4% | 23 / 45 | 58 / 17 | 5M | 11M |
| Q1 2024 | 135 | 39M | 93.3% | 15 / 49 | 58 / 28 | 6M | 5M |
| Q4 2023 | 150 | 38M | 91.3% | 29 / 50 | 54 / 33 | 9M | 6M |
| Q3 2023 | 154 | 35M | 84.2% | 27 / 69 | 44 / 28 | 10M | 10M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ANGO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,173,227 | 2.79% | $15.26M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 973,144 | 2.31% | $12.66M | 0.02% | Jun 30, 2026 |
| Royce Small-Cap Opportunity Fund | 707,398 | 1.68% | $9.20M | 0.65% | Jun 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 626,469 | 1.49% | $8.15M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 484,796 | 1.15% | $6.31M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 406,661 | 0.97% | $6.01M | 0.02% | Jul 31, 2026 |
| Nuveen Quant Small Cap Equity Fund | 382,490 | 0.91% | $5.66M | 0.14% | Jul 31, 2026 |
| First Eagle Small Cap Opportunity Fund | 310,729 | 0.74% | $4.60M | 0.16% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 261,136 | 0.62% | $3.40M | 0.02% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund | 224,372 | 0.53% | $2.58M | 0.05% | May 29, 2026 |
| Fidelity Extended Market Index Fund | 214,612 | 0.51% | $2.46M | 0.01% | May 31, 2026 |
| Sbh Small Cap Value Fund | 205,492 | 0.49% | $2.67M | 0.60% | Jun 30, 2026 |
| Schwab U.S. Small-Cap ETF | 203,599 | 0.48% | $2.34M | 0.01% | May 31, 2026 |
| Paradigm Micro-Cap Fund | 197,900 | 0.47% | $2.57M | 1.40% | Jun 30, 2026 |
| iShares U.S. Medical Devices ETF | 193,491 | 0.46% | $2.52M | 0.08% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| James C. Clemmer | President and CEO, Director | 862,448 | 2.05% | Jul 24, 2026 |
| Warren Nighan JR | SVP Quality and Regulatory | 64,745 | 0.15% | Jul 31, 2026 |
| Laura Piccinini | SVP International | 81,929 | 0.19% | Jul 24, 2026 |
| Chad Thomas Campbell | SVP/GM, Vascular Access | 111,006 | 0.26% | Jul 24, 2026 |
| Stephen A. Trowbridge | EVP and CFO | 314,115 | 0.75% | Jul 24, 2026 |
| Lawrence T. Weiss | SVP, Chief Legal Officer | 112,618 | 0.27% | Jul 22, 2026 |
| Lorinda Burgess | Director | 67,144 | 0.16% | Jul 22, 2026 |
| Eileen O'Shea Auen | Director | 116,605 | 0.28% | Jul 22, 2026 |
| Jan Stern Reed | Director | 116,921 | 0.28% | Jul 22, 2026 |
| Michael E. Tarnoff | Director | 95,265 | 0.23% | Jul 22, 2026 |
| Wesley Johnson | Director | 155,425 | 0.37% | Jul 22, 2026 |
| Karen A. Licitra | Director | 102,322 | 0.24% | Jul 22, 2026 |
| Howard W. Donnelly | Director | 178,938 | 0.43% | Jul 22, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Warren Nighan JR SVP Quality and Regulatory | Jul 30, 2026 | Sale | −23,370 | $14.72 | $344.01K | 64,745 |
| Chad Thomas Campbell SVP/GM, Vascular Access | Jul 22, 2026 | Option exercise | +6,466 | – | – | 111,006 |
| Chad Thomas Campbell SVP/GM, Vascular Access | Jul 22, 2026 | Tax withholding | −2,330 | $13.82 | $32.20K | 108,676 |
| James C. Clemmer President and CEO, Director | Jul 22, 2026 | Tax withholding | −26,728 | $13.82 | $369.38K | 862,448 |
| James C. Clemmer President and CEO, Director | Jul 22, 2026 | Option exercise | +52,358 | – | – | 889,176 |
| Laura Piccinini SVP International | Jul 22, 2026 | Tax withholding | −4,506 | $13.82 | $62.27K | 81,929 |
| Laura Piccinini SVP International | Jul 22, 2026 | Option exercise | +8,047 | – | – | 86,435 |
| Stephen A. Trowbridge EVP and CFO | Jul 22, 2026 | Option exercise | +16,296 | – | – | 314,115 |
| Stephen A. Trowbridge EVP and CFO | Jul 22, 2026 | Tax withholding | −8,319 | $13.82 | $114.97K | 305,796 |
| Warren Nighan JR SVP Quality and Regulatory | Jul 22, 2026 | Tax withholding | −1,671 | $13.82 | $23.09K | 88,115 |
| Warren Nighan JR SVP Quality and Regulatory | Jul 22, 2026 | Option exercise | +5,694 | – | – | 89,786 |
| Stephen A. Trowbridge EVP and CFO | Jul 20, 2026 | Tax withholding | −717 | $13.71 | $9.83K | 244,562 |
| James C. Clemmer President and CEO, Director | Jul 20, 2026 | Tax withholding | −4,223 | $13.71 | $57.90K | 836,818 |
| Warren Nighan JR SVP Quality and Regulatory | Jul 20, 2026 | Tax withholding | −251 | $13.71 | $3.44K | 66,126 |
| Chad Thomas Campbell SVP/GM, Vascular Access | Jul 20, 2026 | Tax withholding | −359 | $13.71 | $4.92K | 88,459 |
| Laura Piccinini SVP International | Jul 20, 2026 | Tax withholding | −616 | $13.71 | $8.45K | 58,528 |
| James C. Clemmer President and CEO, Director | Jul 19, 2026 | Tax withholding | −11,764 | $13.51 | $158.93K | 841,528 |
| James C. Clemmer President and CEO, Director | Jul 19, 2026 | Tax withholding | −487 | $13.51 | $6.58K | 841,041 |
| Stephen A. Trowbridge EVP and CFO | Jul 17, 2026 | Tax withholding | −3,510 | $13.51 | $47.42K | 245,279 |
| James C. Clemmer President and CEO, Director | Jul 17, 2026 | Tax withholding | −10,649 | $13.51 | $143.87K | 853,292 |
| Warren Nighan JR SVP Quality and Regulatory | Jul 17, 2026 | Tax withholding | −1,373 | $13.51 | $18.55K | 66,377 |
| Chad Thomas Campbell SVP/GM, Vascular Access | Jul 17, 2026 | Tax withholding | −1,112 | $13.51 | $15.02K | 88,818 |
| Laura Piccinini SVP International | Jul 17, 2026 | Tax withholding | −3,074 | $13.51 | $41.53K | 59,144 |
| Stephen A. Trowbridge EVP and CFO | Jul 16, 2026 | Tax withholding | −7,840 | $14.14 | $110.86K | 248,789 |
| Lawrence T. Weiss SVP, Chief Legal Officer | Jul 16, 2026 | Tax withholding | −2,267 | $14.14 | $32.06K | 91,330 |
| James C. Clemmer President and CEO, Director | Jul 16, 2026 | Tax withholding | −18,588 | $14.14 | $262.83K | 863,941 |
| Warren Nighan JR SVP Quality and Regulatory | Jul 16, 2026 | Tax withholding | −2,153 | $14.14 | $30.44K | 67,750 |
| Chad Thomas Campbell SVP/GM, Vascular Access | Jul 16, 2026 | Tax withholding | −2,367 | $14.14 | $33.47K | 89,930 |
| Laura Piccinini SVP International | Jul 16, 2026 | Tax withholding | −4,538 | $14.14 | $64.17K | 62,218 |
| Warren Nighan JR SVP Quality and Regulatory | Jul 15, 2026 | Award | +17,966 | – | – | 84,092 |
| Eileen O'Shea Auen Director | Jul 15, 2026 | Award | +11,887 | – | – | 116,605 |
| Lorinda Burgess Director | Jul 15, 2026 | Award | +11,887 | – | – | 67,144 |
| Howard W. Donnelly Director | Jul 15, 2026 | Award | +11,887 | – | – | 178,938 |
| Jan Stern Reed Director | Jul 15, 2026 | Award | +11,887 | – | – | 116,921 |
| Stephen A. Trowbridge EVP and CFO | Jul 15, 2026 | Award | +53,257 | – | – | 297,819 |
| Karen A. Licitra Director | Jul 15, 2026 | Award | +11,887 | – | – | 102,322 |
| Wesley Johnson Director | Jul 15, 2026 | Award | +11,887 | – | – | 155,425 |
| Laura Piccinini SVP International | Jul 15, 2026 | Award | +19,860 | – | – | 78,388 |
| Lawrence T. Weiss SVP, Chief Legal Officer | Jul 15, 2026 | Award | +21,288 | – | – | 112,618 |
| Michael E. Tarnoff Director | Jul 15, 2026 | Award | +11,887 | – | – | 95,265 |
| Chad Thomas Campbell SVP/GM, Vascular Access | Jul 15, 2026 | Award | +16,081 | – | – | 104,540 |
| Lawrence T. Weiss SVP, Chief Legal Officer | Oct 21, 2025 | Buy | +10,000 | $11.81 | $118.10K | 93,597 |
| Stephen A. Trowbridge EVP and CFO | Oct 13, 2025 | Buy | +890 | $11.16 | $9.93K | 256,629 |
| James C. Clemmer President and CEO, Director | Oct 9, 2025 | Buy | +10,000 | $11.15 | $111.50K | 882,529 |
| Warren Nighan JR SVP Quality and Regulatory | Jul 21, 2025 | Tax withholding | −277 | $8.99 | $2.49K | 69,903 |
| Stephen A. Trowbridge EVP and CFO | Jul 21, 2025 | Tax withholding | −667 | $8.99 | $6.00K | 255,739 |
| Chad Thomas Campbell SVP/GM, Vascular Access | Jul 21, 2025 | Tax withholding | −395 | $8.99 | $3.55K | 92,297 |
| Warren Nighan JR SVP Quality and Regulatory | Jul 20, 2025 | Tax withholding | −251 | $8.69 | $2.18K | 70,180 |
| Stephen A. Trowbridge EVP and CFO | Jul 20, 2025 | Tax withholding | −717 | $8.69 | $6.23K | 256,406 |
| Laura Piccinini SVP International | Jul 20, 2025 | Tax withholding | −616 | $8.69 | $5.35K | 66,756 |
| James C. Clemmer President and CEO, Director | Jul 20, 2025 | Tax withholding | −2,982 | $8.69 | $25.91K | 876,202 |
| James C. Clemmer President and CEO, Director | Jul 20, 2025 | Tax withholding | −3,673 | $8.99 | $33.02K | 872,529 |
| Chad Thomas Campbell SVP/GM, Vascular Access | Jul 20, 2025 | Tax withholding | −359 | $8.69 | $3.12K | 92,692 |
| Warren Nighan JR SVP Quality and Regulatory | Jul 19, 2025 | Tax withholding | −735 | $8.69 | $6.39K | 70,431 |
| Stephen A. Trowbridge EVP and CFO | Jul 19, 2025 | Tax withholding | −2,585 | $8.69 | $22.46K | 257,123 |
| Laura Piccinini SVP International | Jul 19, 2025 | Tax withholding | −1,983 | $8.69 | $17.23K | 67,372 |
| James C. Clemmer President and CEO, Director | Jul 19, 2025 | Tax withholding | −344 | $8.69 | $2.99K | 887,491 |
| James C. Clemmer President and CEO, Director | Jul 19, 2025 | Tax withholding | −8,307 | $8.69 | $72.19K | 879,184 |
| Chad Thomas Campbell SVP/GM, Vascular Access | Jul 19, 2025 | Tax withholding | −1,025 | $8.69 | $8.91K | 93,051 |
| Laura Piccinini SVP International | Jul 17, 2025 | Tax withholding | −3,074 | $8.74 | $26.87K | 69,355 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Nighan Warren Officer | Jul 30, 2026 | 23,370 | $344.00K | Jul 30, 2026 | Restricted Stock |
| Warren Nighan JR Officer | Jan 16, 2025 | 4,060 | $49.98K | Jan 16, 2025 | PERFORMANCE SHARES |